Champions Oncology, Inc. (CSBR)

Champions Oncology Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	10.12	9.01	4.69	8.34	3.24
Cash & Cash Equivalents	10.12	9.01	4.69	8.34	3.24
Cash Growth	12.33%	92.17%	-43.81%	157.71%	221.77%
Receivables	8.01	9.51	6.99	4.77	4.38
Other Current Assets	1.33	1.14	0.96	0.39	0.31
Total Current Assets	19.46	19.66	12.63	13.5	7.92
Property, Plant & Equipment	14.5	15.36	14.61	6.79	2.55
Goodwill and Intangibles	0.34	0.34	0.34	0.34	0.67
Other Long-Term Assets	0.02	0.02	0.02	0.13	0.13
Total Long-Term Assets	14.85	15.71	14.96	7.25	3.34
Total Assets	34.31	35.38	27.59	20.75	11.27
Accounts Payable	5.33	2.87	1.89	3.14	2.81
Deferred Revenue	12.78	11.07	6.26	5.82	4.02
Current Debt	1.21	1.05	0.82	0.63	0.02
Other Current Liabilities	2.42	2.49	2.23	2.72	1.18
Total Current Liabilities	21.73	17.48	11.2	12.3	8.03
Long-Term Debt	7.39	8.41	8.78	3.17	0
Other Long-Term Liabilities	0.55	0.39	0.18	0.18	1
Total Long-Term Liabilities	7.94	8.8	8.96	3.35	1
Total Liabilities	29.68	26.28	20.16	15.65	9.03
Total Debt	8.6	9.47	9.6	3.8	0.02
Debt Growth	-9.16%	-1.41%	152.79%	23637.50%	-62.79%
Retained Earnings	-77.32	-71.98	-72.53	-72.89	-70.7
Shareholders' Equity	4.64	9.1	7.43	5.1	2.24
Net Cash / Debt	1.52	-0.46	-4.91	4.54	3.22
Net Cash / Debt Growth	-	-	-	41.07%	234.48%
Net Cash Per Share	0.11	-0.03	-0.34	0.38	0.23
Working Capital	-2.28	2.19	1.43	1.19	-0.1
Book Value Per Share	0.34	0.69	0.56	0.43	0.20

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).